T cell Immunotherapy animation launched
26 January 2023
A new animation explores work by the Chakraverty Group, Vyas Group, and Professor Borrow from the Jenner Institute.
Patient priorities guide Oxford Myeloma research
29 March 2022
Medical staff in Oxford are partnering closely with Myeloma patients to help set priorities for future research.
Spin-out company Alethiomics launches
15 December 2021
The enterprise will focus on developing targeted therapies for a specific family of blood cancers.
Interview with Excellence Award winner Dr Susan Shapiro
9 December 2021
A member of the Oxford Centre For Haematology, Dr Shapiro, was recently interviewed by the Royal College of Pathologists.
New model for infant leukaemia announced
25 November 2021
The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.
Focus on racism- making a difference for sickle cell disease
27 October 2021
Project aims to increase understanding, reduce stigma, and improve the quality of life of people living with sickle cell disease.
Giulia Orlando becomes a John Goldman Fellow
19 October 2021
Many congratulations to Dr Giulia Orlando, who has become a 2021 Leukaemia UK John Goldman Fellow.
New atlas revealed of bone marrow haematopoiesis during development
29 September 2021
A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.
Changes in blood cell production over the human lifetime may hold clues to patterns of disease
16 September 2021
Centre for Computational Biology MRC MHU OCH Paediatrics
A new paper published in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.
New clinical trial for patients affected by blood cancer
27 May 2021
Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.
New funding for early diagnosis research using platelets
30 March 2021
Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.